Literature DB >> 10841912

Diagnostic value of urinary alanine aminopeptidase and N-acetyl-beta-D-glucosaminidase in comparison to alpha 1-microglobulin as a marker in evaluating tubular dysfunction in glomerulonephritis patients.

B Holdt-Lehmann1, A Lehmann, G Korten, H Nagel, H Nizze, P Schuff-Werner.   

Abstract

To estimate the diagnostic value of tubular parameters, the urinary alanine aminopeptidase (AAP), N-acetyl-beta-D-glucosaminidase (NAG) and the alpha(1)-microglobulin (a1M) of 150 patients with histologically proven glomerulonephritis (GN) were determined. In addition, the reabsorption rate of the proximal tubule and the fractional excretion of sodium, the free water clearance and the renal function were assessed by inulin and p-aminohippurate (PAH) clearance. Compared to healthy controls, urinary AAP, NAG and a1M were found significantly elevated in GN patients. Morphological tubular changes were confirmed by significant differences in urinary laboratory parameters. In patients with tubular atrophy, the diagnostic sensitivity and specificity were calculated as follows: AAP (0.94/0.35), NAG (0.75/0.59) and a1M (0.73/0.52). In patients showing tubular protein droplets, the values were 0.90/0.17 for AAP, 0.78/0.76 for NAG and 0.84/0.74 for a1M and in patients with interstitial fibrosis, the values were AAP (0.95/0.35), NAG (0.75/0. 46) and a1M (68/0.38). Urinary AAP, NAG and a1M reflect histologically proven tubulus alteration in GN, although in most cases, the renal function is still intact. AAP indicates very early tubular impairment and, in some cases, AAP is elevated although NAG and a1M are still within normal ranges. We suggest that the enzyme activities are useful in the diagnostics of early stages of the disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10841912     DOI: 10.1016/s0009-8981(00)00237-0

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

1.  Urinary enzymatic markers (N-acetyl-beta-D-glucosaminidase) in assessing the tubulointerstitial compartment in chronic glomerulonephritis related to odontogenic foci.

Authors:  Silvia Velciov; Gheorghe Gluhovschi; Romulus Timar; Cristina Gluhovschi; Ligia Petrica; Flaviu Bob; Gheorghe Bozdog; Marius Pricop; Adrian Gluhovschi; Marioara Cornianu; Elena Potencz; Bogdan Timar; Adriana Kaycsa
Journal:  Wien Klin Wochenschr       Date:  2015-09-16       Impact factor: 1.704

2.  The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?

Authors:  Federica Genovese; Alba A Manresa; Diana Julie Leeming; Morten Asser Karsdal; Peter Boor
Journal:  Fibrogenesis Tissue Repair       Date:  2014-03-28

3.  Renal effects of dental amalgam in children: the New England children's amalgam trial.

Authors:  Lars Barregard; Felicia Trachtenberg; Sonja McKinlay
Journal:  Environ Health Perspect       Date:  2008-03       Impact factor: 9.031

Review 4.  Biomarkers of Renal Disease and Progression in Patients with Diabetes.

Authors:  Radovan Hojs; Robert Ekart; Sebastjan Bevc; Nina Hojs
Journal:  J Clin Med       Date:  2015-05-19       Impact factor: 4.241

5.  The renoprotective effect of concomitant fosfomycin in the treatment of pulmonary exacerbations in cystic fibrosis.

Authors:  Mohamed Al-Aloul; Dilip Nazareth; Martin Walshaw
Journal:  Clin Kidney J       Date:  2019-02-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.